Vaccine Adjuvants Market by Type , Administration and Application - Global Industry Analysis and Forecast to 2023

Published On : December 2017 Pages : 80 Category: Pharmaceuticals Report Code : HC12419

Industry Outlook and Trend Analysis

The global Vaccine Adjuvants market was worth USD 0.32 billion in the year 2014 and is expected to reach approximately USD 0.80 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.89% during the forecast period. Growing prevalence of cervical tumor, irresistible sicknesses, for example, Human Papillomavirus (HPV), HIV, tuberculosis, and so on, and other lethal ailments is relied upon to help the interest for adjuvants. In expansion, developing spotlight on enduring impact of inoculation against existing and rising infections is required to support interest for adjuvants. The significance of adjuvant research for improvement of these items has expanded essentially because of lacking immunogenicity of imaginative immunization antigens. In addition, the expanding utilization of recombinant and manufactured immunizations is required to quicken development of this market in the coming years.

Type Outlook and Trend Analysis

On the basis of Type, the global Vaccine Adjuvants market is segmented into Pathogen, Adjuvant Emulsion, Particulate, Combination and other types. Particulate type held the biggest piece of the pie in 2016, trailed by adjuvant emulsion. This vast offer can be credited to the nearness of extensive variety of items and more prominent proficiency against the diseases. Particulate type incorporates adjuvants comprising of alum, virosomes, and cytokines. Alum is the most ordinarily utilized adjuvant comprising of aluminum salts. It is essentially utilized as a part of hepatitis B and HPV antibodies. Virosomes that are particles looking like noninfectious infections are utilized as adjuvants in hepatitis A, Epaxal and Influenza vaccine Inflexal.

Application Outlook and Trend Analysis

On the basis of Application, the worldwide Vaccine Adjuvants market is segmented into Infectious Diseases, Cancer and other applications. Infectious diseases represented the biggest offer in the vaccine adjuvants market. This vast offer can be ascribed to slowly developing predominance of irresistible ailments, for example, jungle fever, flu, hepatitis A, B, and C, and others. Moreover, the nearness of solid pipeline items for immunization adjuvants identified with irresistible illnesses is foreseen to fuel the market development in the coming years. This incorporates CpG (TLR 9 agonist) vaccine adjuvant from InvivoGen. The product is in phase 3 of clinical trial and gives CD8 T cell-interceded resistance and Th1-sort invulnerability.

 Administration Outlook and Trend Analysis

On the basis of Administration, the global Vaccine Adjuvant market is segmented into Oral, Intradermal, Intranasal, Intramuscular and other administrations. The intramuscular section represented the biggest piece of the overall industry in 2016 because of better resistant specificity. These incorporate antibodies for HPV, flu, meningitis, and so forth. The viability of antibodies relies upon the course of organization. For example, alum salts, which are the most broadly utilized parenteral adjuvants, are ineffectual when regulated by the oral or nasal course.

Regional Outlook and Trend Analysis

North America held the biggest piece of the overall industry in 2016 took after by Europe. The variables adding to development of vaccine adjuvants market in the North American area are ascend in ventures for R&D of new therapeutics and increment in lethal plague maladies. In this manner, prompting the requirement for inoculation against intense and constant illnesses. Likewise, nearby nearness of key market players in the U.S. expands the entrance of items. For example, Adjuvance Technologies, Inc. has created arrangement of adjuvants focused toward treatment of different illness.

Competitive Insights

The key players of global vaccine adjuvants market report incorporate GlaxoSmithKline plc.; Novavax, Inc.; Adjuvance Technologies, Inc.; SPI Pharma.; Agenus, Inc.; CSL Limited; InvivoGen; and Brenntag Biosector.

The Vaccine Adjuvants Market is segmented as follows-

By Type:

  • Pathogen
  • Adjuvant Emulsion
  • Particulate
  • Combination
  • Other Types

By Administration:

  • Oral
  • Intradermal
  • Intranasal
  • Intramuscular
  • Other Administrations

By Application:

  • Infectious Diseases
  • Cancer
  • Other Applications

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2014 to 2023?
  • What will be the industry market growth from 2014 to 2023?
  • What are the major drivers, restraints, opportunities, challenges and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Vaccine Adjuvants Market , By Type, Estimates and Forecast, 2014-2023($Billion)
    • Pathogen
    • Adjuvant Emulsion
    • Particulate
    • Combination
    • Other Types
  • Vaccine Adjuvants Market , By Administration, Estimates and Forecast, 2014-2023($Billion)
    • Oral
    • Intradermal
    • Intranasal
    • Intramuscular
    • Other Administrations
  • Vaccine Adjuvants Market , By Application, Estimates and Forecast, 2014-2023($Billion)
    • Infectious Diseases
    • Cancer
    • Other Applications
  • Vaccine Adjuvants Market , By Region, Estimates and Forecast, 2014-2023($Billion)
    • North America
  • North America Vaccine Adjuvants Market , By Country
  • North America Vaccine Adjuvants Market , By Type
  • North America Vaccine Adjuvants Market , By Administration
  • North America Vaccine Adjuvants Market , By Application
    • U.S. Vaccine Adjuvants Market , By Type
    • U.S. Vaccine Adjuvants Market , By Administration
    • U.S. Vaccine Adjuvants Market , By Application
    • Canada Vaccine Adjuvants Market , By Type
    • Canada Vaccine Adjuvants Market , By Administration
    • Canada Vaccine Adjuvants Market , By Application
    • Mexico Vaccine Adjuvants Market , By Type
    • Mexico Vaccine Adjuvants Market , By Administration
    • Mexico Vaccine Adjuvants Market , By Application

 

    • Europe
      • Europe Vaccine Adjuvants Market , By Country
      • Europe Vaccine Adjuvants Market , By Type
      • Europe Vaccine Adjuvants Market , By Administration
      • Europe Vaccine Adjuvants Market , By Application
        • Germany Vaccine Adjuvants Market , By Type
        • Germany Vaccine Adjuvants Market , By Administration
        • Germany Vaccine Adjuvants Market , By Application
        • France Vaccine Adjuvants Market , By Type
        • France Vaccine Adjuvants Market , By Administration
        • France Vaccine Adjuvants Market , By Application
        • UK Vaccine Adjuvants Market , By Type
        • UK Vaccine Adjuvants Market , By Administration
        • UK Vaccine Adjuvants Market , By Application
        • Italy Vaccine Adjuvants Market , By Type
        • Italy Vaccine Adjuvants Market , By Administration
        • Italy Vaccine Adjuvants Market , By Application
        • Spain Vaccine Adjuvants Market , By Type
        • Spain Vaccine Adjuvants Market , By Administration
        • Spain Vaccine Adjuvants Market , By Application
        • Rest of Europe Vaccine Adjuvants Market , By Type
        • Rest of Europe Vaccine Adjuvants Market , By Administration
        • Rest of Europe Vaccine Adjuvants Market , By Application
    • Asia-Pacific
      • Asia-Pacific Vaccine Adjuvants Market , By Country
      • Asia-Pacific Vaccine Adjuvants Market , By Type
      • Asia-Pacific Vaccine Adjuvants Market , By Administration
      • Asia-Pacific Vaccine Adjuvants Market , By Application
        • Japan Vaccine Adjuvants Market , By Type
        • Japan Vaccine Adjuvants Market , By Administration
        • Japan Vaccine Adjuvants Market , By Application
        • Australia Vaccine Adjuvants Market , By Type
        • Australia Vaccine Adjuvants Market , By Administration
        • Australia Vaccine Adjuvants Market , By Application
        • India Vaccine Adjuvants Market , By Type
        • India Vaccine Adjuvants Market , By Administration
        • India Vaccine Adjuvants Market , By Application
        • South Korea Vaccine Adjuvants Market , By Type
        • South Korea Vaccine Adjuvants Market , By Administration
        • South Korea Vaccine Adjuvants Market , By Application
        • Rest of Asia-Pacific Vaccine Adjuvants Market , By Type
        • Rest of Asia-Pacific Vaccine Adjuvants Market , By Administration
        • Rest of Asia-Pacific Vaccine Adjuvants Market , By Application
    • Rest of the World
      • Rest of the World Vaccine Adjuvants Market , By Country
      • Rest of the World Vaccine Adjuvants Market , By Type
      • Rest of the World Vaccine Adjuvants Market , By Administration
      • Rest of the World Vaccine Adjuvants Market , By Application
        • Brazil Vaccine Adjuvants Market , By Type
        • Brazil Vaccine Adjuvants Market , By Administration
        • Brazil Vaccine Adjuvants Market , By Application
        • South Africa Vaccine Adjuvants Market , By Type
        • South Africa Vaccine Adjuvants Market , By Administration
        • South Africa Vaccine Adjuvants Market , By Application
        • Saudi Arabia Vaccine Adjuvants Market , By Type
        • Saudi Arabia Vaccine Adjuvants Market , By Administration
        • Saudi Arabia Vaccine Adjuvants Market , By Application
        • Turkey Vaccine Adjuvants Market , By Type
        • Turkey Vaccine Adjuvants Market , By Administration
        • Turkey Vaccine Adjuvants Market , By Application
        • United Arab Emirates Vaccine Adjuvants Market , By Type
        • United Arab Emirates Vaccine Adjuvants Market , By Administration
        • United Arab Emirates Vaccine Adjuvants Market , By Application
        • Others Vaccine Adjuvants Market , By Type
        • Others Vaccine Adjuvants Market , By Administration
        • Others Vaccine Adjuvants Market , By Application

1.      Introduction

1.1.      Report Description

1.2.      Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2.      Executive Summary

2.1.      Key Highlights

3.      Market Overview

3.1.      Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.      Market Dynamics

3.2.1. Drivers

3.2.1.1.   Increasing Use of Adjuvants in Vaccine

3.2.1.2.   Increase in Livestock and Instances of Diseases 

3.2.1.3.   Technological Advancements in Aluminum Hydroxide-Based Adjuvants

3.2.2. Restraints

3.2.2.1.   Stringent Regulatory Environment and Time-Consuming Approvals

3.2.2.2.   High Cost of Adjuvant Research

3.2.3. Opportunities

3.2.3.1.   Emerging Countries to Offer Lucrative Growth Opportunities

4.      Vaccine Adjuvants Market, By Type

4.1.      Introduction

4.2.      Vaccine Adjuvants Market Assessment and Forecast, By Type, 2014-2023

4.3.      Pathogen

4.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

4.4.      Adjuvant Emulsion

4.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

4.5.      Particulate

4.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

4.6.      Combination

4.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

4.7.      Other Types

4.7.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

5.      Vaccine Adjuvants Market, By Administration

5.1.      Introduction

5.2.      Vaccine Adjuvants Market  Assessment and Forecast, By Administration, 2014-2023

5.3.      Oral

5.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

5.4.      Intradermal

5.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

5.5.      Intranasal

5.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

5.6.      Intramuscular

5.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

5.7.      Other Administrations

5.7.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

6.      Vaccine Adjuvants Market, By Application

6.1.      Introduction

6.2.      Vaccine Adjuvants Market  Assessment and Forecast, By Application, 2014-2023 ($Billion)

6.3.      Infectious Diseases

6.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

6.4.      Cancer

6.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

6.5.      Other Applications

6.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Billion)

7.      Vaccine Adjuvants Market, By Region

7.1.      Introduction

7.2.      Vaccine Adjuvants Market  Assessment and Forecast, By Region, 2014-2023 ($Billion)

7.3.      North America

7.3.1. Market Assessment and Forecast, By Country, 2014-2023 ($Billion)

7.3.2. Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.3.3. Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.3.4. Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.3.5. U.S.

7.3.5.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.3.5.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.3.5.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

 

7.3.5.2.   Canada

7.3.5.2.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.3.5.2.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.3.5.2.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.3.5.3.   Mexico

7.3.5.3.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.3.5.3.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.3.5.3.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.      Europe

7.4.1. Market Assessment and Forecast, By Country, 2014-2023 ($Billion)

7.4.2. Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.3. Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.4. Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.5. Germany

7.4.5.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.5.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.4.5.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.6. France

7.4.6.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.6.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.4.6.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.7. UK

7.4.7.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.7.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.4.7.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.8. Italy

7.4.8.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.8.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.4.8.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.9. Spain

7.4.9.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.9.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.4.9.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

7.4.9.2.   Rest of Europe

7.4.9.2.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

7.4.9.2.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

7.4.9.2.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.      Asia-Pacific

8.1.1. Market Assessment and Forecast, By Country, 2014-2023 ($Billion)

8.1.2. Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.3. Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.4. Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.1.4.1.   Japan

8.1.4.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.4.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.4.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.1.5. China

8.1.5.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.5.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.5.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.1.6. Australia

8.1.6.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.6.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.6.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.1.7. India

8.1.7.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.7.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.7.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.1.8. South Korea

8.1.8.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.8.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.8.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

8.1.9. Rest of Asia-Pacific

8.1.9.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

8.1.9.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

8.1.9.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.      Rest of the World

9.1.1. Market Assessment and Forecast, By Country, 2014-2023 ($Billion)

9.1.2. Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.3. Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.4. Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.5. Brazil

9.1.5.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.5.1.2.   Market Assessment and Forecast, By Administration , 2014-2023 ($Billion)

9.1.5.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.6. Turkey

9.1.6.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.6.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

9.1.6.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.7. Saudi Arabia

9.1.7.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.7.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

9.1.7.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.8. South Africa

9.1.8.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.8.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

9.1.8.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.9. United Arab Emirates

9.1.9.1.1.   Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.9.1.2.   Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

9.1.9.1.3.   Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

9.1.10.    Others

9.1.10.1.1.                Market Assessment and Forecast, By Type, 2014-2023 ($Billion)

9.1.10.1.2.                Market Assessment and Forecast, By Administration, 2014-2023 ($Billion)

9.1.10.1.3.                Market Assessment and Forecast, By Application, 2014-2023 ($Billion)

10.   Company Profiles

10.1.     GSK

10.1.1.    Business Overview

10.1.2.    Product Portfolio

10.1.3.    Key Financials

10.1.4.    Strategic Developments

10.2.   Novartis/CSL

10.2.1.    Business Overview

10.2.2.    Product Portfolio

10.2.3.    Key Financials

10.2.4.    Strategic Developments

10.3.   Agenus

10.3.1.    Business Overview

10.3.2.    Product Portfolio

10.3.3.    Key Financials

10.3.4.    Strategic Developments

10.4.   Adjuvance

10.4.1.    Business Overview

10.4.2.    Product Portfolio

10.4.3.    Key Financials

10.4.4.    Strategic Developments

10.5.   Novavax

10.5.1.    Business Overview

10.5.2.    Product Portfolio

10.5.3.    Strategic Developments

10.6.   SPI Pharma

10.6.1.    Business Overview

10.6.2.    Product Portfolio

10.6.3.    Strategic Developments

10.7.    Invivogen

10.7.1.    Business Overview

10.7.2.    Product Portfolio

10.7.3.    Strategic Developments

10.8.   Avanti Polar Lipids

10.8.1.    Business Overview

10.8.2.    Product Portfolio

10.8.3.    Strategic Developments

10.9.   Brentagg

10.9.1.    Business Overview

10.9.2.    Product Portfolio

10.9.3.    Key Financials

10.9.4.Strategic Developments


List of Tables

Table 1.Global Vaccine Adjuvants Market, By Type ($Billion), 2014-2023
Table 2.Product Market, By Region ($Billion), 2014-2023
Table 3.Adjuvant Emulsion Market, By Region ($Billion), 2014-2023
Table 4.Particulate Market, By Region ($Billion), 2014-2023
Table 5.Combination Market, By Region ($Billion), 2014-2023
Table 6.Other Types Market, By Region ($Billion), 2014-2023
Table 7.Global Vaccine Adjuvants Market, By Administration ($Billion), 2014-2023
Table 8.Oral Market, By Region ($Billion), 2014-2023
Table 9.Intradermal Market, By Region ($Billion), 2014-2023
Table 10.Intranasal Market, By Region ($Billion), 2014-2023
Table 11.Intramuscular Market, By Region ($Billion), 2014-2023
Table 12.Other Administrations Market, By Region ($Billion), 2014-2023
Table 13.Global Vaccine Adjuvants Market, By Applications ($Billion), 2014-2023
Table 14.Infectious Diseases Market, By Region ($Billion), 2014-2023
Table 15.Cancer Market, By Region ($Billion), 2014-2023
Table 16.Other Applications Market, By Region ($Billion), 2014-2023
Table 17.North America Vaccine Adjuvants Market, By Country, 2014-2023 ($Billion)
Table 18.North America Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 19.North America Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 20.North America Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 21.U.S. Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 22.U.S. Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 23.U.S. Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 24.Canada Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 25.Canada Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 26.Canada Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 27.Mexico Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 28.Mexico Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 29.Mexico Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 30.Europe Vaccine Adjuvants Market, By Country, 2014-2023 ($Billion)
Table 31.Europe Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 32.Europe Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 33.Europe Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 34.Germany Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 35.Germany Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 36.Germany Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 37.France Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 38.France Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 39.France Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 40.UK Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 41.UK Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 42.UK Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 43.Italy Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 44.Italy Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 45.Italy Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 46.Spain Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 47.Spain Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 48.Spain Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 49.Rest of Europe Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 50.Rest of Europe Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 51.Rest of Europe Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 52.Asia-Pacific Vaccine Adjuvants Market, By Country, 2014-2023 ($Billion)
Table 53.Asia-Pacific Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 54.Asia-Pacific Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 55.Asia-Pacific Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 56.Japan Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 57.Japan Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 58.Japan Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 59.China Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 60.China Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 61.China Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 62.Australia Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 63.Australia Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 64.Australia Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 65.India Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 66.India Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 67.India Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 68.South Korea Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 69.South Korea Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 70.South Korea Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 71.Rest of Asia-Pacific Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 72.Rest of Asia-Pacific Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 73.Rest of Asia-Pacific Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 74.Rest of the World Vaccine Adjuvants Market, By Country, 2014-2023 ($Billion)
Table 75.Rest of the World Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 76.Rest of the World Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 77.Rest of the World Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 78.Brazil Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 79.Brazil Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 80.Brazil Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 81.Turkey Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 82.Turkey Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 83.Turkey Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 84.Saudi Arabia Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 85.Saudi Arabia Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 86.Saudi Arabia Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 87.South Africa Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 88.South Africa Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 89.South Africa Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 90.United Arab Emirates Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 91.United Arab Emirates Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 92.United Arab Emirates Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 93.Others Vaccine Adjuvants Market, By Type, 2014-2023 ($Billion)
Table 94.Others Vaccine Adjuvants Market, By Administration, 2014-2023 ($Billion)
Table 95.Others Vaccine Adjuvants Market, By Application, 2014-2023 ($Billion)
Table 96.GSK: Key Strategic Developments, 2015-2017
Table 97.Novartis/CSL: Key Strategic Developments, 2015-2017
Table 98.Agenus: Key Strategic Developments, 2015-2017
Table 99.Adjuvance: Key Strategic Developments, 2015-2017
Table 100.Novavax: Key Strategic Developments, 2015-2017
Table 101.SPI Pharma: Key Strategic Developments, 2015-2017
Table 102.Invivogen: Key Strategic Developments, 2015-2017
Table 103.Avanti Polar Lipids: Key Strategic Developments, 2015-2017
Table 104.Brentagg: Key Strategic Developments, 2015-2017


List of Figures

Figure 1.Vaccine Adjuvants Market Share, By Type, 2014 & 2023 ($Billion)
Figure 2.Vaccine Adjuvants Market, By Administration, 2014 & 2023 ($Billion)
Figure 3.Vaccine Adjuvants Market, By Application, 2014 & 2023 ($Billion)
Figure 4.Vaccine Adjuvants Market, By Region, 2014 & 2023 ($Billion)
Figure 5.GSK: Net Revenues, 2014-2016 ($Billion)
Figure 6.GSK: Net Revenue Share, By Segment, 2016
Figure 7.GSK: Net Revenue Share, By Geography, 2016
Figure 8.Novartis/CSL: Net Revenues, 2014-2016 ($Billion)
Figure 9.Novartis/CSL: Net Revenue Share, By Segment, 2016
Figure 10.Novartis/CSL: Net Revenue Share, By Geography, 2016
Figure 11.Agenus: Net Revenues, 2014-2016 ($Billion)
Figure 12.Agenus: Net Revenue Share, By Segment, 2016
Figure 13.Agenus: Net Revenue Share, By Geography, 2016
Figure 14.Adjuvance: Net Revenues, 2014-2016 ($Billion)
Figure 15.Adjuvance: Net Revenue Share, By Segment, 2016
Figure 16.Adjuvance: Net Revenue Share, By Geography, 2016
Figure 14.Brentagg: Net Revenues, 2014-2016 ($Billion)
Figure 15.Brentagg: Net Revenue Share, By Segment, 2016
Figure 16.Brentagg: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*